Adient (NYSE:ADNT) Price Target Raised to $20.00 at UBS Group

Adient (NYSE:ADNT – Get Free Report) had its target price upped by stock analysts at UBS Group from $19.00 to $20.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has a “neutral” rating on the stock. UBS Group’s price objective would suggest a potential upside of 7.33% from […]

Leave a Reply

Your email address will not be published.

Previous post Vanguard Value ETF (NYSEARCA:VTV) Stock Position Lifted by Strategic Blueprint LLC
Next post Swedbank AB Acquires 261,275 Shares of SS&C Technologies Holdings, Inc. (NASDAQ:SSNC)